Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Three Developmental Domains01:29

Three Developmental Domains

Human development is typically examined across three main domains: physical, cognitive, and socio-emotional. These domains represent the significant areas of change and continuity throughout the lifespan, from infancy to late adulthood.
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Introduction to Developmental Psychology01:27

Introduction to Developmental Psychology

Developmental psychology explores the changes and continuities in human abilities throughout life, encompassing physical, cognitive, linguistic, and social dimensions. Human development is not restricted to growth, but includes aspects of decline, particularly in physical abilities as individuals age. Developmental psychologists seek to understand how people change as they age and how their mental and social skills evolve.Developmental MilestonesA key concept in developmental psychology is...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal psychological distress and temperament traits in children from infancy to late childhood.

JCPP advances·2024
Same author

Childhood Developmental Milestones and Risk of Adult Cerebrovascular Disease: The Northern Finland Birth Cohort 1966.

Cerebrovascular diseases (Basel, Switzerland)·2024
Same author

Sensitivity of the familial high-risk approach for the prediction of future psychosis: a total population study.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2024
Same author

Large-scale exome array summary statistics resources for glycemic traits to aid effector gene prioritization.

Wellcome open research·2024
Same author

Romantic and sexual relationships of young adults born very preterm: An individual participant data meta-analysis.

Acta paediatrica (Oslo, Norway : 1992)·2024
Same author

A Finnish nationwide register-based study shows a further 50% decline in already low child mortality.

Acta paediatrica (Oslo, Norway : 1992)·2024

Related Experiment Video

Updated: Jun 20, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

[From preterm birth to adulthood].

Kaija Mikkola1, Viena Tommiska, Petteri Hovi

  • 1HUS:n lasten ja nuorten sairaala, neonatologian yksikkö, PL 800, 00029 HUS.

Duodecim; Laaketieteellinen Aikakauskirja
|August 29, 2009
PubMed
Summary

Outcomes for low birthweight infants have improved, but many still face neurological impairments and cardiovascular risks. Despite challenges, most achieve normal adult lives with fewer high-risk behaviors.

Area of Science:

  • Neonatal care
  • Developmental pediatrics
  • Perinatal epidemiology

Context:

  • Significant advancements in neonatal intensive care have improved survival rates for low birthweight infants.
  • Despite improved outcomes, a substantial proportion of extremely low birthweight infants (birthweight < 1000 g) experience significant neurological impairments.
  • Long-term neurodevelopmental and health trajectories for these infants require continued investigation.

Purpose:

  • To assess the neurological prognosis and long-term health outcomes for infants born with low birthweight.
  • To identify persistent challenges and risk factors associated with prematurity.
  • To understand the adult life course of individuals born with very low birthweight.

Summary:

  • Mortality rates for low birthweight infants have declined, with notable improvements in neurological prognosis over recent decades.

More Related Videos

Preterm EEG: A Multimodal Neurophysiological Protocol
19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Related Experiment Videos

Last Updated: Jun 20, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Preterm EEG: A Multimodal Neurophysiological Protocol
19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

  • Approximately one-fifth of infants born weighing less than 1000 grams exhibit major neurological impairments by preschool age.
  • While most low birthweight survivors lead relatively normal adult lives, they face increased cardiovascular disease risk factors compared to full-term infants, yet display less high-risk behavior.
  • Impact:

    • Highlights the need for ongoing neurodevelopmental surveillance and targeted interventions for extremely low birthweight survivors.
    • Informs clinical practice regarding the long-term management of cardiovascular risk in this vulnerable population.
    • Provides insights into the complex interplay between prematurity, neurodevelopment, and adult health behaviors.